Blood Transfusion
Studies in the Area of Blood Transfusion Reported from Emory University Hospital
Published in Blood Weekly, March 10th, 2011
2011 MAR 10 -- "Aprotinin, once used to reduce allogeneic blood product transfusion during cardiac surgery, was withdrawn from the market in late 2007 over concerns of causing increased mortality. This study was undertaken to determine what, if any, the impact of changing antifibrinolytic agents (from aprotinin to tranexamic acid) for deep hypothermic circulatory arrest cases would have on blood bank resource utilization," scientists writing in the Journal of Cardiothoracic and Vascular Anesthesia report.
"This a retrospective review. All cases were performed at a single university hospital. All patients underwent cardiac surgical procedures...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2011-03-10)
More Articles from Blood Weekly
- Blood Research
Findings from M. Ikeda and Co-Authors Provide New Insights into Blood Research - Blood Research
Investigators at University of Coimbra Publish New Data on Blood Research - Sepsis
Research Data from D.G. Maki and Colleagues Update Understanding of Sepsis - Transplantation
Researchers from Harvard University Describe Findings in Transplantation - Blood Transfusion
Studies from Kyushu University in the Area of Blood Transfusion Described - Aneurysm
Data on Aneurysm Discussed by G.S. Georgiadis and Colleagues - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
